BAZAN RUSSO, Tancredi Didier
 Distribuzione geografica
Continente #
EU - Europa 1.261
NA - Nord America 1.105
AS - Asia 966
SA - Sud America 165
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 38
OC - Oceania 6
Totale 3.703
Nazione #
US - Stati Uniti d'America 1.034
RU - Federazione Russa 424
SG - Singapore 375
IT - Italia 350
CN - Cina 195
DE - Germania 149
BR - Brasile 131
FI - Finlandia 112
VN - Vietnam 102
HK - Hong Kong 79
FR - Francia 67
BD - Bangladesh 65
PL - Polonia 60
CA - Canada 38
JP - Giappone 34
IN - India 31
GB - Regno Unito 29
NL - Olanda 22
IQ - Iraq 17
AR - Argentina 13
KR - Corea 12
MX - Messico 12
ZA - Sudafrica 10
AT - Austria 9
ES - Italia 8
TR - Turchia 8
KE - Kenya 7
IE - Irlanda 6
JM - Giamaica 6
PK - Pakistan 6
SA - Arabia Saudita 6
SE - Svezia 6
AU - Australia 5
CI - Costa d'Avorio 5
EG - Egitto 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
IR - Iran 4
MA - Marocco 4
MY - Malesia 4
PT - Portogallo 4
VE - Venezuela 4
CO - Colombia 3
LT - Lituania 3
MM - Myanmar 3
NP - Nepal 3
PE - Perù 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ID - Indonesia 2
LV - Lettonia 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TN - Tunisia 2
UA - Ucraina 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CL - Cile 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
NG - Nigeria 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.542
Città #
Singapore 229
Ashburn 212
San Jose 157
Palermo 102
Munich 86
Moscow 85
Helsinki 84
Hong Kong 69
Rome 61
The Dalles 54
Zgierz 51
Dallas 48
Los Angeles 39
Beijing 38
Hefei 35
New York 34
Ho Chi Minh City 33
Council Bluffs 31
Tokyo 31
Santa Clara 28
Hanoi 27
Lauterbourg 25
Frankfurt am Main 24
Chicago 21
Milan 18
Buffalo 15
Lappeenranta 15
São Paulo 14
Orem 11
Boardman 10
Montreal 10
Nuremberg 10
Redondo Beach 10
Atlanta 9
Toronto 9
Chennai 8
Denver 8
Houston 8
London 8
Warsaw 8
Memphis 7
Mexico City 7
Philadelphia 7
Seoul 7
Volla 7
Baghdad 6
Boston 6
Johannesburg 6
Mumbai 6
Nairobi 6
Paris 6
Salt Lake City 6
Tappahannock 6
Abidjan 5
Bexley 5
Haiphong 5
Ludwigshafen am Rhein 5
Messina 5
Naples 5
New Delhi 5
Phoenix 5
Rio de Janeiro 5
Roubaix 5
Turin 5
Turku 5
Biên Hòa 4
Brasília 4
Bắc Giang 4
Cairo 4
Curitiba 4
Da Nang 4
Erbil 4
Jyväskylä 4
Las Vegas 4
Melbourne 4
Monza 4
Stockholm 4
Vienna 4
Brooklyn 3
Campinas 3
Casamassima 3
Dammam 3
Dhaka 3
Dublin 3
Falkenstein 3
Guarulhos 3
Hải Dương 3
Jacksonville 3
Kingston 3
Legnano 3
Lima 3
Manchester 3
Montevideo 3
Querétaro 3
Quito 3
Rancho Palos Verdes 3
San Francisco 3
Shanghai 3
Shenzhen 3
Staten Island 3
Totale 2.036
Nome #
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 322
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer 193
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 181
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 165
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 165
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 164
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 160
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 154
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 153
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 150
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 142
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 141
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 140
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 132
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 128
Scientific Communication and oncology – "The bridge between knowledge and patients" 127
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors 125
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 124
Recent advances in liquid biopsy for precision oncology: emerging biomarkers and clinical applications in lung cancer 122
Potential Applications of PRP-Enhanced Polybutylene Succinate Graft as Vascular Access for Chemotherapy in Oncological Patients: A Systematic Review 117
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitors 110
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study 102
POLE-mutated endometrial cancer: new perspectives on the horizon? 93
Genomics and the early diagnosis of lung cancer 91
Smaller, Cheaper, Faster: Where Next for Liquid Biopsies? 90
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 56
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer 54
Global Real-World Outcomes of Olaparib in Metastatic Castration-Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations 1
Liquid biopsy in Oncology: Results of a Delphi consensus study endorsed by the AIOM-SIAPEC/IAP-SIBioC-SIF Italian scientific societies 1
Totale 3.703
Categoria #
all - tutte 11.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202322 0 0 0 0 0 1 7 7 2 1 3 1
2023/2024144 1 5 5 6 22 36 20 6 5 16 2 20
2024/2025883 30 36 66 40 41 76 153 77 55 119 103 87
2025/20262.452 185 91 188 233 249 397 341 224 181 124 113 126
2026/2027202 68 72 62 0 0 0 0 0 0 0 0 0
Totale 3.703